Michael Greiner - 07 Mar 2025 Form 4 Insider Report for AVANOS MEDICAL, INC. (AVNS)

Role
Interim CEO
Signature
/s/ Mojirade James, as attorney-in-fact for Michael C. Greiner
Issuer symbol
AVNS
Transactions as of
07 Mar 2025
Net transactions value
$0
Form type
4
Filing time
11 Mar 2025, 16:54:56 UTC
Previous filing
10 Mar 2025
Next filing
14 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVNS Common Stock Award $0 +34,316 +18% $0.000000 224,264 07 Mar 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVNS Employee Stock Option (right to buy) Award $0 +73,633 $0.000000 73,633 07 Mar 2025 Common Stock 73,633 $15.24 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents time-based restricted share units (TRSUs) awarded pursuant to the Issuer's 2021 Long Term Incentive Plan, as amended. The award will vest 1/3 on March 7, 2026, 1/3 on March 7, 2027 and 1/3 on March 7, 2028. Each TRSU is the economic equivalent of one share of Common Stock.
F2 The award will vest 30% on March 7, 2026, 30% on March 7, 2027 and 40% on March 7, 2028.